These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20043566)
21. [Pediatric kidney transplantation and living donors--invaluable by virtue of necessity]. Leumann E; Goetschel P; Neuhaus TJ; Ambühl PM; Candinas D Schweiz Med Wochenschr; 2000 Oct; 130(43):1581-9. PubMed ID: 11100511 [TBL] [Abstract][Full Text] [Related]
22. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604 [TBL] [Abstract][Full Text] [Related]
23. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338 [TBL] [Abstract][Full Text] [Related]
24. What is the calcineurin inhibitor of choice for pediatric renal transplantation? Kari JA; Trompeter RS Pediatr Transplant; 2004 Oct; 8(5):437-44. PubMed ID: 15367278 [TBL] [Abstract][Full Text] [Related]
25. Rapamycin in patients with chronic renal allograft dysfunction. Wu MS; Chang CT; Hung CC Clin Transplant; 2005 Apr; 19(2):236-42. PubMed ID: 15740561 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
27. Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. Urbizu JM; Amenabar JJ; Gomez-Ullate P; Zarraga S; Lampreabe I Transplant Proc; 2002 Feb; 34(1):87-8. PubMed ID: 11959197 [No Abstract] [Full Text] [Related]
28. Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea. Lee S; Shin M; Kim E; Kim JM; Moon J; Jung G; Choi G; Kwon C; Joh J; Lee S; Kim S Transplant Proc; 2010 Apr; 42(3):793-6. PubMed ID: 20430174 [TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial. Höcker B; Weber LT; Bunchman T; Rashford M; Tönshoff B; Pediatr Transplant; 2005 Aug; 9(4):504-11. PubMed ID: 16048604 [TBL] [Abstract][Full Text] [Related]
35. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]
36. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843 [TBL] [Abstract][Full Text] [Related]
37. Pediatric renal transplantation with mycophenolate mofetil immunosuppression in a single center from Mexico. Martinez-Mier G; Mendez-Lopez MT; Budar-Fernandez LF; Estrada-Oros J; Franco-Abaroa R; George-Micelli E; Rios-Martinez L; Calzada-Grijalva JF; Gonzalez-Velazquez F Pediatr Transplant; 2007 Mar; 11(2):134-8. PubMed ID: 17300491 [TBL] [Abstract][Full Text] [Related]
38. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Boratyńska M; Banasik M; Patrzałek D; Klinger M Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290 [TBL] [Abstract][Full Text] [Related]